$HCTI
Healthcare Triangle, Inc. Stock $hcti

$hcti Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000160706222000662 Filed on November 10, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$11.29M	$11.95M	$8.078M
YoY Change	22.89%	47.93%	9.76%
Cost Of Revenue	$9.478M	$8.522M	$5.352M
YoY Change	36.97%	59.24%	-0.15%
Gross Profit	$1.814M	$3.428M	$2.727M
YoY Change	-20.06%	25.72%	36.33%
Gross Profit Margin	16.06%	28.69%	33.75%
Selling, General & Admin	$2.895M	$3.295M	$2.082M
YoY Change	-13.28%	58.28%	96.39%
% of Gross Profit	159.59%	96.12%	76.35%
Research & Development	$2.770M	$1.471M	$2.204M
YoY Change	86.82%	-33.26%	300.73%
% of Gross Profit	152.7%	42.91%	80.83%
Depreciation & Amortization	$910.0K	$909.0K	$211.3K
YoY Change	15.44%	330.13%	5.67%
% of Gross Profit	50.17%	26.52%	7.75%
Operating Expenses	$6.575M	$5.675M	$4.497M
YoY Change	17.21%	26.19%	148.46%
Operating Profit	-$4.761M	-$2.247M	-$1.770M
YoY Change	42.54%	26.91%	-1031.84%
Interest Expense	-$83.00K	-$55.00K	-$220.6K
YoY Change	-4.48%	-75.07%
% of Operating Profit
Other Income/Expense, Net	-$6.000K	$0.00	$0.00
YoY Change
Pretax Income	-$4.850M	-$2.302M	-$1.991M
YoY Change	41.52%	15.61%	-1147.96%
Income Tax	$12.00K	$37.00K	$940.00
% Of Pretax Income
Net Earnings	-$4.863M	-$2.339M	-$1.992M
YoY Change	41.1%	17.42%	-1522.91%
Net Earnings / Revenue	-43.07%	-19.57%	-24.66%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.13	-$64.93K	-$51.16K
COMMON SHARES
Basic Shares Outstanding	41.63M shares	39.47M shares	28.84M shares
Diluted Shares Outstanding		36.02M shares	28.84M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.341M	$4.144M	$1.148M
YoY Change	-24.22%	260.84%
Cash & Equivalents	$1.341M	$4.144M	$1.148M
Short-Term Investments
Other Short-Term Assets	$816.0K	$233.0K	$691.4K
YoY Change	125.41%	-66.3%
Inventory
Prepaid Expenses
Receivables	$5.592M	$6.702M	$6.673M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.749M	$11.08M	$8.513M
YoY Change	-34.35%	30.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$80.00K	$76.00K	$51.81K
YoY Change	8.11%	46.69%
Goodwill	$1.289M	$1.289M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$13.01M	$13.79M	$2.878M
YoY Change	1.6%	378.94%
TOTAL ASSETS
Total Short-Term Assets	$7.749M	$11.08M	$8.513M
Total Long-Term Assets	$13.01M	$13.79M	$2.878M
Total Assets	$20.76M	$24.86M	$11.39M
YoY Change	-15.64%	118.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.481M	$1.468M	$2.632M
YoY Change	-20.93%	-44.23%
Accrued Expenses	$0.00	$41.00K
YoY Change	-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.412M	$2.453M	$3.021M
YoY Change	9.19%	-18.81%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.148M	$5.060M	$8.683M
YoY Change	-1.65%	-41.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.227M	$2.227M
YoY Change
Total Long-Term Liabilities	$2.227M	$2.227M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.148M	$5.060M	$8.683M
Total Long-Term Liabilities	$2.227M	$2.227M	$0.00
Total Liabilities	$8.375M	$7.287M	$8.683M
YoY Change	-1.21%	-16.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.57M	-$7.419M
YoY Change	371.77%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.48M	$17.58M	$2.708M
YoY Change
Total Liabilities & Shareholders Equity	$20.76M	$24.86M	$11.39M
YoY Change	-15.64%	118.28%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$4.863M	-$2.339M	-$1.992M
YoY Change	41.1%	17.42%	-1522.91%
Depreciation, Depletion And Amortization	$910.0K	$909.0K	$211.3K
YoY Change	15.44%	330.13%	5.67%
Cash From Operating Activities	-$2.228M	-$974.0K	-$391.4K
YoY Change	-34.78%	148.86%	-39.79%
INVESTING ACTIVITIES
Capital Expenditures	$14.00K	-$1.283M	-$10.16K
YoY Change	-100.45%	12527.95%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$14.00K	-$1.283M	-$10.16K
YoY Change	-99.82%	12527.95%	-201.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-561.0K	5.038M	0.000
YoY Change	-104.83%
NET CHANGE
Cash From Operating Activities	-2.228M	-974.0K	-391.4K
Cash From Investing Activities	-14.00K	-1.283M	-10.16K
Cash From Financing Activities	-561.0K	5.038M	0.000
Net Change In Cash	-2.803M	2.781M	-401.5K
YoY Change	-551.28%	-792.58%	-37.26%
FREE CASH FLOW
Cash From Operating Activities	-$2.228M	-$974.0K	-$391.4K
Capital Expenditures	$14.00K	-$1.283M	-$10.16K
Free Cash Flow	-$2.242M	$309.0K	-$381.2K
YoY Change	564.3%	-181.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	HCTI	Payroll Protection Program PayrollProtectionProgram		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001839285
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	HCTI	Common Share Warrants CommonShareWarrants		usd
	HCTI	Income From Payroll Protection Program IncomeFromPayrollProtectionProgram		usd
	HCTI	Warrant Fair Valuation Expenses WarrantFairValuationExpenses		usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments		usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	HCTI	Increase In Payroll Protection Program IncreaseInPayrollProtectionProgram		usd
CY2022Q3	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2021Q3	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2022Q3	HCTI	Other Income Amount Changes OtherIncomeAmountChanges		usd
	us-gaap	Other Noncash Income OtherNoncashIncome		usd
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q3	HCTI	Business Combination Working Capital BusinessCombinationWorkingCapital		usd
CY2021Q4	HCTI	Other Income Loan Forgiveness OtherIncomeLoanForgiveness		usd
CY2022Q3	HCTI	Fair Value Of Warrant FairValueOfWarrant		usd
CY2022Q3	HCTI	Deferredtaxassetnetofvaluationallowance Deferredtaxassetnetofvaluationallowance		usd
CY2021Q4	HCTI	Deferredtaxassetnetofvaluationallowance Deferredtaxassetnetofvaluationallowance		usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
	dei	Trading Symbol TradingSymbol	HCTI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40903
	dei	Entity Registrant Name EntityRegistrantName	HEALTHCARE TRIANGLE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3559776
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7901 Stoneridge Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 220
	dei	Entity Address City Or Town EntityAddressCityOrTown	Pleasanton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94588
	dei	City Area Code CityAreaCode	(925)
	dei	Local Phone Number LocalPhoneNumber	270-4812
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41634232	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4144000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1770000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6702000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9672000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	233000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	362000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	11079000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	11804000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	172000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11427000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10458000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	1289000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1289000	usd
CY2022Q3	us-gaap	Due From Affiliates DueFromAffiliates	950000	usd
CY2021Q4	us-gaap	Due From Affiliates DueFromAffiliates	816000	usd
CY2022Q3	us-gaap	Assets Assets	24864000	usd
CY2021Q4	us-gaap	Assets Assets	24613000	usd
CY2022Q3	HCTI	Warrant Liability WarrantLiability	55000	usd
CY2021Q4	HCTI	Warrant Liability WarrantLiability	55000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1468000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1873000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	8478000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	HCTI	Preferred Stock Voting Shares PreferredStockVotingShares	6000	shares
CY2021Q4	HCTI	Preferred Stock Voting Shares PreferredStockVotingShares	6000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	HCTI	Payroll Protection Program PayrollProtectionProgram	1069000	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	2453000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2209000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	41000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	176000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1043000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	869000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5060000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6251000	usd
CY2022Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	2227000	usd
CY2021Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	2227000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	7287000	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39466671	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39466671	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35260834	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35260834	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24996000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18799000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7419000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2664000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	17577000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16135000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24864000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24613000	usd
CY2022Q3	us-gaap	Revenues Revenues	11950000	usd
CY2021Q3	us-gaap	Revenues Revenues	8078000	usd
	us-gaap	Revenues Revenues	34594000	usd
	us-gaap	Revenues Revenues	26081000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	8522000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	5352000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	25113000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	17829000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2464000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	633000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1471000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2204000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3183000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3775000	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1815000	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1328000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	5206000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2801000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1480000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	753000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4282000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3062000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	909000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	211000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5675000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	4496000	usd
	us-gaap	Operating Expenses OperatingExpenses	15135000	usd
	us-gaap	Operating Expenses OperatingExpenses	10271000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2247000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1770000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5654000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2019000	usd
	us-gaap	Other Income OtherIncome	1087000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-55000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-221000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-129000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-480000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2302000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1991000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4696000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2499000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2339000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1992000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4747000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2504000	usd
CY2022Q3	HCTI	Net Income Per Common Sharebasic And Diluted NetIncomePerCommonSharebasicAndDiluted	-0.07
CY2021Q3	HCTI	Net Income Per Common Sharebasic And Diluted NetIncomePerCommonSharebasicAndDiluted	-0.07
	HCTI	Net Income Per Common Sharebasic And Diluted NetIncomePerCommonSharebasicAndDiluted	-0.13
	HCTI	Net Income Per Common Sharebasic And Diluted NetIncomePerCommonSharebasicAndDiluted	-0.09
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36022893	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28839889	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36022893	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28839889	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36022893	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28839889	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36022893	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28839889	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	14106000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13000	usd
CY2022Q3	HCTI	Issuance Of Common Stock In Connection With Private Placement IssuanceOfCommonStockInConnectionWithPrivatePlacement	3580000	usd
CY2022Q3	HCTI	Issuance Of Warrants In Connection With Private Placement IssuanceOfWarrantsInConnectionWithPrivatePlacement	2308000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	91000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-2339000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	17577000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	4444000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	19000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	236000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-1992000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	2707000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16135000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	32000	usd
	HCTI	Cash Collected On Common Stock Options CashCollectedOnCommonStockOptions	10000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	350000	usd
	HCTI	Issuance Of Common Stock In Connection With Private Placement IssuanceOfCommonStockInConnectionWithPrivatePlacement	3580000	usd
	HCTI	Issuance Of Warrants In Connection With Private Placement IssuanceOfWarrantsInConnectionWithPrivatePlacement	2308000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	91000	usd
	us-gaap	Profit Loss ProfitLoss	-4747000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	17577000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4328000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	836000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	47000	usd
	us-gaap	Profit Loss ProfitLoss	-2504000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	2707000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4747000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2504000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2464000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	633000	usd
	HCTI	Income From Payroll Protection Program IncomeFromPayrollProtectionProgram	1069000	usd
	HCTI	Common Stock Issued For Services CommonStockIssuedForServices	350000	usd
	HCTI	Common Stock Issued For Services CommonStockIssuedForServices	836000	usd
	HCTI	Warrant Fair Valuation Expenses WarrantFairValuationExpenses	55000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	40000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	47000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2970000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-487000	usd
	HCTI	Unallocated Costs UnallocatedCosts	7147000	usd
	HCTI	Unallocated Costs UnallocatedCosts	5243000	usd
	HCTI	Less Unallocated Costs Amount Changes LessUnallocatedCostsAmountChanges	1904000	usd
	HCTI	Less Unallocated Costs Percentage Changes LessUnallocatedCostsPercentageChanges	0.36	pure
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5654000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2019000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-129000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	463000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	764000	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	134000	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	381000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-405000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1717000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-31000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	176000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-76000	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	146000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-372000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3878000	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	26000	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	50000	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	3279000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3305000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	244000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2604000	usd
	HCTI	Increase In Additional Paidin Capital IncreaseInAdditionalPaidinCapital	5888000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	91000	usd
	HCTI	Increase In Payroll Protection Program IncreaseInPayrollProtectionProgram	1069000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6051000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3673000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2374000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-255000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1770000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1403000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4144000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1148000	usd
	us-gaap	Interest Expense InterestExpense	129000	usd
	us-gaap	Interest Expense InterestExpense	480000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	51000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	5000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z8V1PsnpM0Q2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zIQ6O4gjEHwc">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements is in conformity with GAAP which requires us to make estimates, judgments and assumptions that affect the financial statements and the notes thereto. These estimates are based on information available as of the date of the financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">•</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the standalone selling price for each distinct performance obligation</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">•</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of the period of benefit for amortization of deferred costs</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">•</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value of assets acquired, and liabilities assumed for business combinations.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">•</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation including warrants.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
	HCTI	Income From Operations Amount Changes IncomeFromOperationsAmountChanges	-3635000	usd
	HCTI	Income From Operations Percentage Changes IncomeFromOperationsPercentageChanges	1.80	pure
CY2021Q3	HCTI	Unallocated Costs UnallocatedCosts	1771000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11950000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8078000	usd
CY2022Q3	HCTI	Changes Amount ChangesAmount	3872000	usd
CY2022Q3	HCTI	Changes Percentage ChangesPercentage	0.48	pure
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	34594000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26081000	usd
	HCTI	Changes Amount ChangesAmount	8513000	usd
	HCTI	Changes Percentage ChangesPercentage	0.33	pure
CY2022Q3	HCTI	Total Segment Operating Profit TotalSegmentOperatingProfit	260000	usd
CY2021Q3	HCTI	Total Segment Operating Profit TotalSegmentOperatingProfit	1000	usd
CY2022Q3	HCTI	Total Segment Operating Profit Amount Changes TotalSegmentOperatingProfitAmountChanges	259000	usd
CY2022Q3	HCTI	Total Segment Operating Profit Percentage Changes TotalSegmentOperatingProfitPercentageChanges	2.59	pure
CY2022Q3	HCTI	Unallocated Costs UnallocatedCosts	2507000	usd
CY2022Q3	HCTI	Less Unallocated Costs Amount Changes LessUnallocatedCostsAmountChanges	736000	usd
CY2022Q3	HCTI	Less Unallocated Costs Percentage Changes LessUnallocatedCostsPercentageChanges	0.42	pure
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2247000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1770000	usd
CY2022Q3	HCTI	Income From Operations Amount Changes IncomeFromOperationsAmountChanges	-477000	usd
CY2022Q3	HCTI	Income From Operations Percentage Changes IncomeFromOperationsPercentageChanges	0.27	pure
CY2022Q3	HCTI	Other Income Percentage Changes OtherIncomePercentageChanges	0	pure
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	55000	usd
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	221000	usd
CY2022Q3	HCTI	Interest Expense Amount Changes InterestExpenseAmountChanges	-166000	usd
CY2022Q3	HCTI	Interest Expense Percentage Changes InterestExpensePercentageChanges	0.75	pure
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2302000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1991000	usd
CY2022Q3	HCTI	Net Income Loss Before Income Tax Expenses Amount Changes NetIncomeLossBeforeIncomeTaxExpensesAmountChanges	-311000	usd
CY2022Q3	HCTI	Net Income Loss Before Income Tax Expenses Percentage Changes NetIncomeLossBeforeIncomeTaxExpensesPercentageChanges	0.16	pure
	HCTI	Total Segment Operating Profit TotalSegmentOperatingProfit	1493000	usd
	HCTI	Total Segment Operating Profit TotalSegmentOperatingProfit	3224000	usd
	HCTI	Total Segment Operating Profit Amount Changes TotalSegmentOperatingProfitAmountChanges	-1731000	usd
	HCTI	Total Segment Operating Profit Percentage Changes TotalSegmentOperatingProfitPercentageChanges	0.54	pure
	us-gaap	Other Noncash Income OtherNoncashIncome	1087000	usd
	HCTI	Other Income Amount Changes OtherIncomeAmountChanges	1087000	usd
	HCTI	Other Income Percentage Changes OtherIncomePercentageChanges	1	pure
	us-gaap	Interest Expense Debt InterestExpenseDebt	129000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	480000	usd
	HCTI	Interest Expense Amount Changes InterestExpenseAmountChanges	-351000	usd
	HCTI	Interest Expense Percentage Changes InterestExpensePercentageChanges	0.73	pure
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4696000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2499000	usd
	HCTI	Net Income Loss Before Income Tax Expenses Amount Changes NetIncomeLossBeforeIncomeTaxExpensesAmountChanges	2197000	usd
	HCTI	Net Income Loss Before Income Tax Expenses Percentage Changes NetIncomeLossBeforeIncomeTaxExpensesPercentageChanges	0.88	pure
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	857	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	206	usd
CY2022Q3	HCTI	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	43000	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	6702000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	9672000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	41000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74000	usd
	us-gaap	Depreciation Depreciation	8000	usd
	us-gaap	Business Development BusinessDevelopment	334000	usd
	us-gaap	Business Development BusinessDevelopment	189000	usd
	us-gaap	Depreciation Depreciation	6000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1527000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1445000	usd
CY2022Q3	HCTI	Stockbased Compensation StockbasedCompensation	-11000	usd
CY2021Q4	HCTI	Stockbased Compensation StockbasedCompensation	-18000	usd
CY2022Q3	HCTI	Other Income Loan Forgiveness OtherIncomeLoanForgiveness	293000	usd
CY2022Q3	HCTI	Warrant Liabilities WarrantLiabilities	55000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2227000	usd
	HCTI	Amount Representing Interest AmountRepresentingInterest	-8000	usd
	HCTI	Total Lease Obligation TotalLeaseObligation	41000	usd
CY2021Q4	HCTI	Fair Value Of Warrant FairValueOfWarrant	-15000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10458000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zUNTNGYuNqpj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zbnIJF6UMemg">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade receivables. Credit risks associated with trade receivables is minimal due to the Company’s customer base which consist of large customer base and ongoing procedures, which monitor the credit worthiness of its customers. For the quarter ended September 30, 2022 and 2021 sales to top five customers accounted for approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zawyqvgOwyHd" title="Concentration Risk, Percentage">76</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20210101__20210930__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zoG03rQkW6w8" title="Concentration Risk, Percentage">79</span>% of total revenue respectively accounts receivable from five major customers accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zNZJX7Uf6F1a" title="Concentration Risk, Percentage">62</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20210101__20210930__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zIq5mZhuBwy8" title="Concentration Risk, Percentage">88</span>% of the total accounts receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances in various financial institutions. The balances are generally insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_c20220930_pn3n3" title="Cash, FDIC Insured Amount">250</span> (valid through September 30, 2022) per institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022, and December 31, 2021, the Company had $<span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_c20220930_pn3n3" title="Cash Equivalents, at Carrying Value">1,453</span> and $<span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_c20211231_pn3n3" title="Cash Equivalents, at Carrying Value">719</span> respectively, of uninsured cash balances. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash</span></p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1453000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	719000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	106000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16473000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13194000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5046000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2736000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11427000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	1714000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	2285000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	2285000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	2285000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	2285000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	573000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11427000	usd
CY2022Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	48000	usd
CY2021Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	54000	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.066
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.065
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5888183000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1809000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1412000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	176000	usd
CY2021	HCTI	Additions Lease Expense AdditionsLeaseExpense	344000	usd
	HCTI	Finance Cost Accrued During Year FinanceCostAccruedDuringYear	10000	usd
CY2021	HCTI	Finance Cost Accrued During Year FinanceCostAccruedDuringYear	13000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	145000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	181000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	41000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	176000	usd
	HCTI	Schedule Of Balance Sheet Releated To Leases Table Textblock ScheduleOfBalanceSheetReleatedToLeasesTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfBalanceSheetReleatedToLeasesTableTextblock_pn3n3_zyb30C1kp9X" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zJZi6a3P3G9g" style="display: none">Schedule of balance sheet related to leases</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_494_20220930_zHoKvCT2UaUh" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended September 30, 2022</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--OperatingLeaseRightOfUseAssets_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 71%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease liabilities, included in current liabilities</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease liabilities, included in long-term liabilities</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1112">—</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiability_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease liabilities</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"/>
CY2022Q3	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	43000	usd
CY2022Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	344000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12M
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
	HCTI	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	49000	usd
	HCTI	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	49000	usd
CY2022Q3	us-gaap	Due From Other Related Parties Noncurrent DueFromOtherRelatedPartiesNoncurrent	383000	usd
CY2021Q3	us-gaap	Due From Other Related Parties Noncurrent DueFromOtherRelatedPartiesNoncurrent	238000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	48000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	54000	usd
CY2022Q3	us-gaap	Due From Related Parties DueFromRelatedParties	950000	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	816000	usd
	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	4500000	usd
	HCTI	Weighted Average Price Of Stock Amount WeightedAveragePriceOfStockAmount	700000	usd
	HCTI	Unvested Common Stock UnvestedCommonStock	83718	shares
	HCTI	Earnout Payment EarnoutPayment	2500000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2209000	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-04-30
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1709000	usd
CY2022Q3	us-gaap	Goodwill Gross GoodwillGross	1289000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	6018000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	1289000	usd
CY2022Q3	us-gaap	Cash Cash	970000	usd
CY2022Q3	HCTI	Business Combination Acquisition Accounts Receivables BusinessCombinationAcquisitionAccountsReceivables	3142000	usd
CY2022Q3	HCTI	Business Combination Acquisition Other Assets Current BusinessCombinationAcquisitionOtherAssetsCurrent	11419000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	758000	usd
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2209000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	679000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities	3646000	usd
CY2022Q3	HCTI	Net Working Capital Acquired NetWorkingCapitalAcquired	7773000	usd
CY2022Q3	HCTI	Total Business Acquisitions Purchase Price TotalBusinessAcquisitionsPurchasePrice	7773000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	146458	shares
CY2022Q3	us-gaap	Share Price SharePrice	0.62
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	91000	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4244000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	0	usd
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	106000	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	2.88
	us-gaap	Other Income OtherIncome	1087000	usd
	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.01	pure
CY2022Q3	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	2453000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55000	usd
	HCTI	Estimated Fair Value Of Common Stock Warrant EstimatedFairValueOfCommonStockWarrant	0.37
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.40
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1809000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1412000	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	37000	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	37000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	usd
	HCTI	Total Income Expenses Benefit TotalIncomeExpensesBenefit	37000	usd
	HCTI	Total Income Expenses Benefit TotalIncomeExpensesBenefit	1000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4000000	shares
CY2021	HCTI	Incentive Stock Options Iso IncentiveStockOptionsIso	1131500	shares
CY2021	HCTI	Nonqualified Stock Options Nso NonqualifiedStockOptionsNso	452000	shares
CY2021	HCTI	Nonqualified Stock Options Nso Directors Stock Options NonqualifiedStockOptionsNsoDirectorsStockOptions	230000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1813500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2186500	shares
	HCTI	Transferred Back To Plan TransferredBackToPlan	-263135	shares
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	399701	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2049934	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2339000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1992000	usd
CY2022Q3	HCTI	Weighted Average Shares Outstanding Used In Basic Per Common Share Computations WeightedAverageSharesOutstandingUsedInBasicPerCommonShareComputations	36022893	shares
CY2021Q3	HCTI	Weighted Average Shares Outstanding Used In Basic Per Common Share Computations WeightedAverageSharesOutstandingUsedInBasicPerCommonShareComputations	28839889	shares
CY2022Q3	HCTI	Weighted Average Shares Outstanding Used In Diluted Per Common Share Computations WeightedAverageSharesOutstandingUsedInDilutedPerCommonShareComputations	36022893	shares
CY2021Q3	HCTI	Weighted Average Shares Outstanding Used In Diluted Per Common Share Computations WeightedAverageSharesOutstandingUsedInDilutedPerCommonShareComputations	28839889	shares
CY2022Q3	HCTI	Weighted Average Basic Diluted Eps WeightedAverageBasicDilutedEps	-0.07	shares
CY2021Q3	HCTI	Weighted Average Basic Diluted Eps WeightedAverageBasicDilutedEps	-0.07	shares

Files In Submission

Name	View Source	Status
0001607062-22-000662-index-headers.html	Edgar Link	pending
0001607062-22-000662-index.html	Edgar Link	pending
0001607062-22-000662.txt	Edgar Link	pending
0001607062-22-000662-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hcti-20220930.xsd	Edgar Link	pending
hcti093022form10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
hcti-20220930_def.xml	Edgar Link	unprocessable
hcti-20220930_cal.xml	Edgar Link	unprocessable
hcti-20220930_lab.xml	Edgar Link	unprocessable
hcti093022form10q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hcti-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCTI
Healthcare Triangle, Inc. Stock $hcti

2022 Q4 Form 10-Q Financial Statement

#000160706222000662 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCTI Healthcare Triangle, Inc. Stock $hcti

2022 Q4 Form 10-Q Financial Statement

#000160706222000662 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCTI
Healthcare Triangle, Inc. Stock $hcti